Dimensional Fund Advisors
CMPX icon

Dimensional Fund Advisors’s Compass Therapeutics CMPX Stock Holding History

Dimensional Fund Advisors’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.18M Buy
541,178
+101,394
+23% +$299K ﹤0.01% 2828
2026
Q1 		$2.32M Buy
439,784
+98,188
+29% +$567K ﹤0.01% 2669
2025
Q4 		$1.83M Buy
341,596
+166,040
+95% +$767K ﹤0.01% 2751
2025
Q3 		$619K Buy
175,556
+3,329
+2% +$10.5K ﹤0.01% 2957
2025
Q2 		$447K Buy
172,227
+33,425
+24% +$68.9K ﹤0.01% 3013
2025
Q1 		$264K Buy
138,802
+127,685
+1,149% +$340K ﹤0.01% 3095
2024
Q4 		$16.1K Hold
11,117
– – ﹤0.01% 3330
2024
Q3 		$20.5K Hold
11,117
– – ﹤0.01% 3334
2024
Q2 		$11.1K Hold
11,117
– – ﹤0.01% 3365
2024
Q1 		$22K Hold
11,117
– – ﹤0.01% 3364
2023
Q4 		$17.3K Sell
11,117
-44
-0.4% -$76 ﹤0.01% 3394
2023
Q3 		$22K Sell
11,161
-19,289
-63% -$47.7K ﹤0.01% 3438
2023
Q2 		$96.8K Buy
+30,450
New +$95.6K ﹤0.01% 3327

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Dimensional Fund Advisors's CMPX Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Compass Therapeutics (CMPX) stake by 23% in Q2 2026, buying an estimated $299K and bringing the position to 541,178 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #2828.

Dimensional Fund Advisors first reported a position in CMPX in Q2 2023 and has held it in 13 quarters since. The position peaked at $2.32M in Q1 2026. 215 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • Dimensional Fund Advisors held 541,178 shares of Compass Therapeutics worth $1.18M as of Q2 2026.
  • Dimensional Fund Advisors bought 101,394 Compass Therapeutics shares in Q2 2026, an estimated $299K.
  • Compass Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2828 holding.
  • Dimensional Fund Advisors first reported a position in Compass Therapeutics in Q2 2023 and has held it in 13 quarters since.
  • Dimensional Fund Advisors's Compass Therapeutics position peaked at $2.32M in Q1 2026.
  • 215 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.